This study is not yet accepting patients
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
Summary
- Eligibility
- for people ages 21-65 (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Neal Benowitz, MD (ucsf)
Description
Summary
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Neal Benowitz, MD (ucsf)
Neal Benowitz has been involved in patient care and conducting research at SFGH since 1973. His research focus is on the human pharmacology of nicotine in relation to pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT05962229
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 18 study participants
- Last Updated